Welcome back,

CONFERENCE UPDATE

ASCO 2025

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

May 30 - Jun 3, 2025 |

Chicago, United States

2025

AI-assisted screening detects early-stage lung cancer in high-risk never-smokers: Interim results from the local LC-SHIELD study

ONCOLOGY
|
RESPIROLOGY

3 Oct 2025
SEER-MHOS analysis supports the use of local estrogen therapy in breast cancer patients

ONCOLOGY
|
OBSTETRICS & GYNECOLOGY

16 Sep 2025
Encorafenib + cetuximab + chemotherapy improves PFS and OS as first-line therapy in BRAF V600E-mutant mCRC: Results from the phase 3 BREAKWATER trial

ONCOLOGY
|
GASTROENTEROLOGY & HEPATOLOGY

15 Sep 2025
Nivolumab + chemotherapy improves long-term survival outcomes in resectable NSCLC: Final OS analysis from the CheckMate 816 trial

ONCOLOGY
|
RESPIROLOGY

7 Sep 2025
Savolitinib + osimertinib prolongs PFS in METamp, EGFR-mutated NSCLC post-first-line EGFR TKI failure: Results from the phase 3 SACHI trial
ONCOLOGY

3 Sep 2025
PSA level post-treatment offers prognostic insight in mHSPC: Real-world analysis of the IRONMAN registry

ONCOLOGY
|
UROLOGY

29 Aug 2025
Structured exercise improves survival outcomes in high-risk stage 2 or stage 3 colon cancer: Results from the CHALLENGE trial

ONCOLOGY
|
GASTROENTEROLOGY & HEPATOLOGY

29 Aug 2025

eaa0190a-4510-467f-900f-c94c7b668484